155 related articles for article (PubMed ID: 10374851)
1. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes.
Hast R; Eriksson M; Widell S; Arvidsson I; Bemell P
Leuk Res; 1999 Jun; 23(6):579-84. PubMed ID: 10374851
[TBL] [Abstract][Full Text] [Related]
2. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
3. Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL; Liang JY
Int J Hematol; 2015 Jan; 101(1):58-66. PubMed ID: 25430081
[TBL] [Abstract][Full Text] [Related]
4. Differences in cell lineage involvement between MDS-AML and de novo AML studied by fluorescence in situ hybridization in combination with morphology.
Bernell P; Arvidsson I; Hast R; Jacobsson B; Stenke L
Eur J Haematol; 1997 Apr; 58(4):241-5. PubMed ID: 9186534
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes.
Hast R; Nilsson I; Widell S; Ost A
Leuk Res; 1989; 13(2):173-8. PubMed ID: 2927174
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
van Lom K; Hagemeijer A; Smit E; Hählen K; Groeneveld K; Löwenberg B
Leukemia; 1995 Nov; 9(11):1818-21. PubMed ID: 7475268
[TBL] [Abstract][Full Text] [Related]
8. Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows.
Li X; Wu L; Ying S; Chang C; Pu Q
Int J Hematol; 2008 Mar; 87(2):176-183. PubMed ID: 18256784
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis in patients with myelodysplastic syndrome.
Hu N; Bian M
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
[TBL] [Abstract][Full Text] [Related]
10. [Study of the clonal origin and development of MDS by FISH analysis of dysplasia cells in bone marrow of patients with MDS].
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):650-6. PubMed ID: 23815916
[TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes.
Widell S; Hellström-Lindberg E; Kock Y; Lindberg M; Ost A; Hast R
Am J Hematol; 1995 Jun; 49(2):115-20. PubMed ID: 7771462
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization to assess aneuploidy for chromosomes 7 and 8 in hematologic disorders.
Wyandt HE; Chinnappan D; Ioannidou S; Salama M; O'Hara C
Cancer Genet Cytogenet; 1998 Apr; 102(2):114-24. PubMed ID: 9546063
[TBL] [Abstract][Full Text] [Related]
15. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
[TBL] [Abstract][Full Text] [Related]
16. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.
Engel H; Goodacre A; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Andreeff M
Br J Haematol; 1997 Oct; 99(1):64-75. PubMed ID: 9359505
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of detection of trisomy 8 with fluorescence in situ hybridization and conventional karyotype analysis in myelodysplastic syndrome].
Zhang ZB; Liu SH; Li J; Bo LJ; Cui HY; Liu XP; Nie YX; Qin S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):115-8. PubMed ID: 12513811
[TBL] [Abstract][Full Text] [Related]
19. Biclonal chromosomal aberrations in a child with myelodysplastic syndrome.
Jakab Z; Balogh E; Kiss C; Pajor L; Oláh E
Cancer Genet Cytogenet; 1999 Jan; 108(1):13-8. PubMed ID: 9973918
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.
Flactif M; Lai JL; Preudhomme C; Fenaux P
Leukemia; 1994 Jun; 8(6):1012-8. PubMed ID: 8207974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
